Schering Claritin, Rebetol Await FDA Certification After Consent Decree
Schering-Plough's first batch of products submitted to FDA for certification under a May 16 consent decree will include the Claritin 10 mg dose and the antiviral Rebetol
Schering-Plough's first batch of products submitted to FDA for certification under a May 16 consent decree will include the Claritin 10 mg dose and the antiviral Rebetol